1-1 of 1
Junko H. Ohyashiki, MD., Ph.D
Close
Sort by
Journal Articles

Mechanism of Action of MK-0457 Efficacy in Monotherapy and in Combination with Vorinostat in Wild Type and T315I Mutant BCR/ABL Positive Leukemia Cells.

Seiichi Okabe, MD, PhD, Tetsuzo Tauchi, MD., Ph.D, Junko H. Ohyashiki, MD., Ph.D, Kazuma Ohyashiki
Journal: Blood
Blood (2007) 110 (11): 1051.
https://doi.org/10.1182/blood.V110.11.1051.1051
Published: 2007